InMed Pharmaceuticals; Revenue and Competitors
Estimated Revenue & Valuation
- InMed Pharmaceuticals;'s estimated annual revenue is currently $3.1M per year.
- InMed Pharmaceuticals;'s estimated revenue per employee is $172,222
Employee Data
- InMed Pharmaceuticals; has 18 Employees.
- InMed Pharmaceuticals; grew their employee count by 13% last year.
InMed Pharmaceuticals;'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO + President, Director | Reveal Email/Phone |
2 | VP Preclinical R&D | Reveal Email/Phone |
3 | VP, Investor Relations and Corporate Communications | Reveal Email/Phone |
4 | SVP, Clinical & Regulatory Affairs | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | VP, Chemistry, Manufacturing & Controls | Reveal Email/Phone |
InMed Pharmaceuticals; Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.1M | 40 | 18% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.3M | 17 | -15% | N/A | N/A |
#4 | $2.6M | 18 | 29% | N/A | N/A |
#5 | $12.9M | 71 | 4% | N/A | N/A |
#6 | $1.9M | 21 | 5% | $89.5M | N/A |
#7 | $2.8M | 15 | 0% | N/A | N/A |
#8 | $40.3M | 260 | 21% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | 33% | N/A | N/A |
What Is InMed Pharmaceuticals;?
InMed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$3.1M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 18 | -5% | $9.5M |
#2 | $2.2M | 18 | N/A | N/A |
#3 | $2.2M | 18 | -5% | N/A |
#4 | $1.5M | 18 | 6% | N/A |
#5 | $1.5M | 18 | 6% | N/A |